Skip to content

4/AAccepted Mar 29, 4:18 PM ET

Eizen Joshua M 4/A

ANTXAN2 Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)

Accepted (ET)

4:18 PM

Mar 29, 2024

Filed

Mar 29, 2024

Documents

1

Size

4.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.